Erythropoietin modulation is associated with improved homing and engraftment after umbilical cord blood transplantation

Blood

Volumn 128, Issue 25, 2016, Pages 3000-3010

  Aljitawi, Omar S ^a,b,c   Paul, Soumen ^b   Ganguly, Avishek ^b   Lin, Tara L ^a   Ganguly, Sid ^a   Vielhauer, George ^b   Capitano, Maegan L ^d   Cantilena, Amy ^a   Lipe, Brea ^a,c   Mahnken, Jonathan D ^b   Wise, Amanda ^a   Berry, Abigale ^a   Singh, Anurag K ^a   Shune, Leyla ^a   Lominska, Christopher ^a   Abhyankar, Sunil ^a   Allin, Dennis ^b   Laughlin, Mary ^e,f   McGuirk, Joseph P ^a   Broxmeyer, Hal E ^d  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Cleveland Cord Blood Center   (United States)

^f Case Western Reserve University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CD38 ANTIGEN; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; STROMAL CELL DERIVED FACTOR 1;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ANEMIA; ANIMAL EXPERIMENT; ARTICLE; BLOOD CELL COUNT; BONE MARROW; BONE MARROW CELL; CELL DIFFERENTIATION; CELL HOMING; CELL KINETICS; CELL MIGRATION; CELL POPULATION; CHIMERA; CLINICAL ARTICLE; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; ENGRAFTMENT; ERYTHROID CELL; FEMALE; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HYPERBARIC OXYGEN THERAPY; LEUKOPENIA; MALE; MIDDLE AGED; MOUSE; NEUTROPENIA; NEUTROPHIL; NONHUMAN; PATIENT SAFETY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REDUCED INTENSITY CONDITIONING; SIGNAL TRANSDUCTION; THROMBOCYTE; UMBILICAL CORD BLOOD CELL; ADVERSE EFFECTS; ANIMAL; CELL MOTION; COHORT ANALYSIS; CYTOLOGY; DRUG EFFECTS; GRAFT VS HOST DISEASE; METABOLISM; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANIMALS; ANTIGENS, CD34; ANTIGENS, CD38; CELL DIFFERENTIATION; CELL MOVEMENT; CHEMOKINE CXCL12; CHIMERISM; COHORT STUDIES; CORD BLOOD STEM CELL TRANSPLANTATION; ERYTHROPOIETIN; FEMALE; GRAFT VS HOST DISEASE; HUMANS; HYPERBARIC OXYGENATION; MALE; MICE; MIDDLE AGED; MYELOID CELLS; RECEPTORS, ERYTHROPOIETIN; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME; YOUNG ADULT;

EID: 85014912184     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2016-05-715292     Document Type: Article

References (22)

1. Barker JN, Byam CE, Kernan NA, et al. Availability of cord blood extends allogeneic hematopoietic stem cell transplant access to racial and ethnic minorities. Biol Blood Marrow Transplant. 2010;16(11):1541-1548.
2. Ballen KK, Gluckman E, Broxmeyer HE. Umbilical cord blood transplantation: the first 25 years and beyond. Blood. 2013;122(4):491-498.
3. Broxmeyer HE, Farag S, Rocha V. Cord Blood Hematopoietic Cell Transplantation. In: Forman SJ, Antin JH, Appelbaum FR, ed. Thomas's Hematopoietic Stem Cell Transplantation. John Wiley and Sons Ltd; 2016:437-455.
4. Migliaccio AR, Adamson JW, Stevens CE, Dobrila NL, Carrier CM, Rubinstein P. Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity. Blood. 2000;96(8):2717-2722.
5. Xia L, McDaniel JM, Yago T, Doeden A, McEver RP. Surface fucosylation of human cord blood cells augments binding to P-selectin and E-selectin and enhances engraftment in bone marrow. Blood. 2004;104(10):3091-3096.
6. Bari S, Seah KK, Poon Z, et al. Expansion and homing of umbilical cord blood hematopoietic stem and progenitor cells for clinical transplantation. Biol Blood Marrow Transplant. 2015;21(6):1008-1019.
7. Grover A, Mancini E, Moore S, et al. Erythropoietin guides multipotent hematopoietic progenitor cells toward an erythroid fate. J Exp Med. 2014;211(2):181-188.
8. Broxmeyer HE, Hangoc G, Cooper S, et al. Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults. Proc Natl Acad Sci USA. 1992;89(9):4109-4113.
9. Gonzalez S, Amat L, Azqueta C, et al. Factors modulating circulation of hematopoietic progenitor cells in cord blood and neonates. Cytotherapy. 2009;11(1):35-42.
10. Balestra C, Germonpré P, Poortmans JR, Marroni A. Serum erythropoietin levels in healthy humans after a short period of normobaric and hyperbaric oxygen breathing: the "normobaric oxygen paradox". J Appl Physiol (1985). 2006;100(2):512-518.
11. + cells in a murine model of umbilical cord blood transplantation. Blood Cells Mol Dis. 2014;52(1):59-67.
12. Broudy VC, Lin N, Brice M, Nakamoto B, Papayannopoulou T. Erythropoietin receptor characteristics on primary human erythroid cells. Blood. 1991;77(12):2583-2590.
13. Barker JN, Byam C, Scaradavou A. How I treat: the selection and acquisition of unrelated cord blood grafts. Blood. 2011;117(8):2332-2339.
14. Shinjo K, Takeshita A, Higuchi M, Ohnishi K, Ohno R. Erythropoietin receptor expression on human bone marrow erythroid precursor cells by a newly-devised quantitative flow-cytometric assay. Br J Haematol. 1997;96(3):551-558.
15. Capitano ML, Broxmeyer HE. CXCL12/SDF-1 and Hematopoiesis, Encyclopedia of Cell Biology. Vol 3. Waltham, MA: Academic Press; 2016.
16. Rio B, Chevret S, Vigouroux S, et al; Société Française de Greffe de Moelle et de Thérapie Cellulaire and Eurocord. Decreased nonrelapse mortality after unrelated cord blood transplantation for acute myeloid leukemia using reduced-intensity conditioning: a prospective phase II multicenter trial. Biol Blood Marrow Transplant. 2015;21(3):445-453.
17. Ballen KK, Spitzer TR, Yeap BY, et al. Double unrelated reduced-intensity umbilical cord blood transplantation in adults. Biol Blood Marrow Transplant. 2007;13(1):82-89.
18. Bradstock K, Hertzberg M, Kerridge I, et al. Single versus double unrelated umbilical cord blood units for allogeneic transplantation in adults with advanced haematological malignancies: a retrospective comparison of outcomes. Intern Med J. 2009;39(11):744-751.
19. Kurtzberg J, Prasad VK, Carter SL, et al; COBLT Steering Committee. Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies. Blood. 2008;112(10):4318-4327.
20. Le Bourgeois A, Mohr C, Guillaume T, et al. Comparison of outcomes after two standards-of-care reduced-intensity conditioning regimens and two different graft sources for allogeneic stem cell transplantation in adults with hematologic diseases: a single-center analysis. Biol Blood Marrow Transplant. 2013;19(6):934-939.
21. Sanz J, Sanz MA, Saavedra S, et al. Cord blood transplantation from unrelated donors in adults with high-risk acute myeloid leukemia. Biol Blood Marrow Transplant. 2010;16(1):86-94.
22. Solh M, Brunstein C, Morgan S, Weisdorf D. Platelet and red blood cell utilization and transfusion independence in umbilical cord blood and allogeneic peripheral blood hematopoietic cell transplants. Biol Blood Marrow Transplant. 2011;17(5):710-716.